Perrigo Recalls Mometasone Furoate Ointment Due to Subpotency
Perrigo recalls 158,268 tubes of Mometasone Furoate Ointment USP 0.1% due to subpotent drug concerns. Check lot numbers and expiration dates.
Use caution until it’s fixed
Subpotent drug
Contact the company
What happened, in plain English
Perrigo Israel Pharmaceuticals is recalling Mometasone Furoate Ointment USP, 0.1%, in 15 g tubes because the drug may be subpotent. The recall affects 158,268 tubes distributed nationwide and in Puerto Rico. Specific lots with expiration dates ranging from April 2016 to July 2017 are included. Read more at govinfonow.com/recall/44096-perrigo-israel-pharmaceuticals-recalls-mometasone-furoate-ointment-usp-0-1.
Source Summary by GovInfoNow · govinfonow.com/recall/44096-perrigo-israel-pharmaceuticals-recalls-mometasone-furoate-ointment-usp-0-1 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1286-2015
Cite this page
“Perrigo Recalls Mometasone Furoate Ointment Due to Subpotency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44096-perrigo-israel-pharmaceuticals-recalls-mometasone-furoate-ointment-usp-0-1. Based on FDA recall #D-1286-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1286-2015%22&limit=1).
Why it’s dangerous
The ointment is classified as a subpotent drug, meaning it may not contain the correct amount of active ingredient. This could result in reduced effectiveness in treating the intended condition.
Who’s affected
Consumers who purchased Mometasone Furoate Ointment USP, 0.1%, 15 g tubes distributed by Perrigo in Allegan, MI. Patients relying on this prescription medication for skin conditions may be affected.
How to tell if you have this one
Check if you have Mometasone Furoate Ointment USP, 0.1%, 15 g tubes manufactured by Perrigo, Yeruham, Israel. Look for NDC 45802-0119-37 and one of the following lot numbers: 063630 (Exp 04/16), 069793 (Exp 11/16), 071745 (Exp 02/17), 076150 (Exp 07/17), or 081317 (Exp 12/17).
- Brand
Perrigo- Category
Drug
What to do — step by step
Check Your Product
Verify if your ointment matches the recalled lot numbers and expiration dates listed in the record.
Consult Your Doctor
Contact your healthcare provider to discuss alternative treatments or next steps since the remedy is not stated in the record.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1286-2015 (July 13, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1286-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.